Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Musculoskeletal

INDICATION: Myotonic dystrophy type 1 (DM1)

Cell culture and mouse studies suggest inhibiting miR-23b

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE